Sertraline promotes hippocampus-derived neural stem cells differentiating into neurons but not glia and attenuates LPS-induced cellular damage

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):183-8. doi: 10.1016/j.pnpbp.2011.08.014. Epub 2011 Aug 25.

Abstract

Sertraline is one of the most commonly used antidepressants in clinic. Although it is well accepted that sertraline exerts its action through inhibition of the reuptake of serotonin at presynaptic site in the brain, its effect on the neural stem cells (NSCs) has not been well elucidated. In this study, we utilized NSCs separated from the hippocampus of fetal rat to investigate the effect of sertraline on the proliferation and differentiation of NSCs. The study demonstrated that sertraline had no effect on NSCs proliferation but it significantly promoted NSCs to differentiate into serotoninergic neurons other than glia cells. Furthermore, we found that sertraline protected NSCs against the lipopolysaccharide-induced cellular damage. These data indicate that sertraline can promote neurogenesis and protect the viability of neural stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Cell Differentiation / drug effects*
  • Cell Differentiation / physiology
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cells, Cultured
  • Female
  • Hippocampus / cytology
  • Hippocampus / drug effects*
  • Hippocampus / pathology
  • Lipopolysaccharides / toxicity*
  • Neural Stem Cells / drug effects*
  • Neural Stem Cells / pathology
  • Neurogenesis / drug effects
  • Neurogenesis / physiology
  • Neuroglia / drug effects*
  • Neuroglia / pathology
  • Neurons / drug effects*
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology
  • Pregnancy
  • Rats
  • Rats, Sprague-Dawley
  • Sertraline / pharmacology*

Substances

  • Lipopolysaccharides
  • Neuroprotective Agents
  • Sertraline